Kerstin Borgmann Selected Research

Kerstin Borgmann Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 10/2007
10	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2003
7	Squamous Cell Carcinoma of Head and Neck 03/2021 - 09/2014
6	Chromosome Aberrations (Chromosome Abnormalities) 12/2016 - 08/2002
5	Fibrosis (Cirrhosis) 01/2015 - 08/2002
4	Lung Neoplasms (Lung Cancer) 04/2019 - 10/2013
3	Triple Negative Breast Neoplasms 09/2020 - 01/2019
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020 - 08/2002
3	Hypersensitivity (Allergy) 04/2018 - 01/2013
3	Genomic Instability 12/2016 - 03/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 03/2016 - 08/2002
3	Fanconi Anemia (Fanconi's Anemia) 10/2013 - 01/2008
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 05/2015
2	Chromosomal Instability (Chromosome Stability) 01/2020 - 10/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 01/2013
2	Erythema 01/2015 - 04/2012
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Cardiotoxicity 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 12/2016
1	Glioma (Gliomas) 11/2016
1	Glioblastoma (Glioblastoma Multiforme) 11/2016
1	Carcinogenesis 08/2016
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016
1	Carcinoma (Carcinomatosis) 10/2014
1	Testicular Neoplasms (Testicular Cancer) 09/2014
1	Melanoma (Melanoma, Malignant) 09/2014
1	Adenocarcinoma 05/2013
1	Blast Crisis (Blast Phase) 01/2011
1	Disease Progression 01/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2008
9	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2008
6	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2019 - 03/2009
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 10/2013
4	olaparibIBA 01/2021 - 10/2013
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2018
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2020 - 01/2020
2	ChromatinIBA 04/2019 - 05/2010
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2013
2	Histones (Histone)IBA 01/2016 - 05/2010
2	Codon (Codons)IBA 04/2012 - 10/2010
2	Carisoprodol (Soma)FDA LinkGeneric 10/2010 - 11/2003
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	ceralasertibIBA 11/2020
1	Messenger RNA (mRNA)IBA 09/2020
1	TensinsIBA 09/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2020
1	desmuslin (synemin)IBA 06/2020
1	Checkpoint Kinase 1IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	NucleotidesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	A 19IBA 04/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2018
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2017
1	trans-sodium crocetinate (crocetin)IBA 12/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2016
1	Lomustine (CCNU)FDA Link 11/2016
1	1-(2-chloroethyl)-1-nitrosourea (CNU)IBA 11/2016
1	fotemustine (Muphoran)IBA 11/2016
1	Alkylating AgentsIBA 11/2016
1	Carmustine (FIVB)FDA Link 11/2016
1	NimustineIBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 08/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2016
1	Antisense OligonucleotidesIBA 02/2016
1	Histone DemethylasesIBA 01/2016
1	histone H3 trimethyl Lys4IBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 05/2015
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2014
1	AntigensIBA 09/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 09/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2013
1	PlatinumIBA 10/2013
1	Calcibiotic Root Canal SealerIBA 05/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 06/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2011

Therapy/Procedure

19	Therapeutics 01/2022 - 08/2002
11	Radiotherapy 01/2021 - 08/2002
2	Drug Therapy (Chemotherapy) 10/2013 - 05/2010
1	Aftercare (After-Treatment) 03/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2018
1	Chemoradiotherapy 05/2015
1	Segmental Mastectomy (Lumpectomy) 01/2015